Syneos Health, Inc. financial data

Industry
Services-Commercial Physical & Biological Research
Location
1030 Sync Street, Morrisville, NC
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INC Research Holdings, Inc. (to 1/3/2018)
Latest financial report
10-Q - Q2 2023 - Aug 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 115 % +7.23%
Debt-to-equity 136 % -7.28%
Return On Equity 2.06 % -75.2%
Return On Assets 0.87 % -74.1%
Operating Margin 3.97 % -50.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104M shares +1.04%
Common Stock, Value, Issued 1.04M USD +1.07%
Weighted Average Number of Shares Outstanding, Basic 104M shares +1.06%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +1.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.42B USD +0.01%
Costs and Expenses 5.2B USD +4.42%
Operating Income (Loss) 215M USD -50.5%
Nonoperating Income (Expense) -132M USD -118%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 82.9M USD -77.9%
Income Tax Expense (Benefit) 11.7M USD -87.9%
Net Income (Loss) Attributable to Parent 71.2M USD -74.4%
Earnings Per Share, Basic 0.69 USD/shares -74.4%
Earnings Per Share, Diluted 0.7 USD/shares -73.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.95B USD +3.71%
Deferred Income Tax Assets, Net 57.6M USD +71.2%
Property, Plant and Equipment, Net 237M USD -7.14%
Operating Lease, Right-of-Use Asset 96M USD -48.1%
Intangible Assets, Net (Excluding Goodwill) 608M USD -19.9%
Goodwill 4.91B USD +0.28%
Other Assets, Noncurrent 213M USD +4.71%
Assets 8.08B USD -1.72%
Accounts Payable, Current 137M USD +38%
Accrued Liabilities, Current 618M USD -5.93%
Contract with Customer, Liability, Current 804M USD -9.39%
Liabilities, Current 1.63B USD -4.7%
Deferred Income Tax Liabilities, Net 69.3M USD -16%
Operating Lease, Liability, Noncurrent 150M USD -17.4%
Other Liabilities, Noncurrent 58.2M USD +6.93%
Liabilities 4.58B USD -6.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -106M USD +13.9%
Retained Earnings (Accumulated Deficit) 96.3M USD +284%
Stockholders' Equity Attributable to Parent 3.49B USD +4.95%
Liabilities and Equity 8.08B USD -1.72%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 30.4M USD -57.1%
Net Cash Provided by (Used in) Financing Activities 199K USD
Net Cash Provided by (Used in) Investing Activities -27.6M USD -8.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -949K USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 82.3M USD -22.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 88.2M USD +11.6%
Payments to Acquire Property, Plant, and Equipment 27.5M USD +17.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 88.3M USD -51.3%
Operating Lease, Liability, Current 39.5M USD -2.24%
Deferred Income Tax Expense (Benefit) -12.1M USD -1305%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 19.8M USD +69.2%
Additional Paid in Capital 3.5B USD +2.23%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 156M USD -4.78%
Depreciation, Depletion and Amortization 61.6M USD -0.99%
Interest Expense 113M USD +68.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%